Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AZD 6482

Next Previous
Drug Profile

AZD 6482

Alternative Names: AZD6482; KIN 193; TBO-309

Latest Information Update: 15 Dec 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator AstraZeneca
  • Developer AstraZeneca; ThromBio
  • Class Antithrombotics
  • Mechanism of Action Phosphatidylinositol 3 kinase beta inhibitors; Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Ischaemic stroke
  • Preclinical Prostate cancer
  • No development reported Thrombosis

Most Recent Events

  • 04 Oct 2025 ThromBio initiate a phase II (CO-STARS) trial for Ischaemic stroke (Adjunctive therapy) in Australia (IV) (NCT06813651)
  • 28 Jul 2025 No recent reports of development identified for phase-I development in Thrombosis(In volunteers) in Sweden (IV, Infusion)
  • 05 Jun 2025 The Florey Institute of Neuroscience and Mental Health terminates a phase II STARS trial in Ischaemic stroke(Adjunctive treatment) in Australia (IV) due to funding issues (NCT05363397)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top